Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on the day's biggest business stories

Subscribe to Axios Closer for insights into the day’s business news and trends and why they matter

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Stay on top of the latest market trends

Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Illustration: Annelise Capossela/Axios

Technology companies including IBM, Oracle, and Salesforce are working with governments and health agencies to manage the massive task of rapidly distributing the COVID-19 vaccines.

Why it matters: It's critical to make sure the limited supply of vaccines is distributed equitably and without wasting precious doses.

Driving the news:

  • Salesforce has a number of efforts to help agencies distributing the vaccine. Internationally, it is working with Gavi to help that global vaccine agency with its project to equitably distribute the vaccine in 190 countries. Closer to home, Salesforce is part of a project that consultant MTX built for the city of Chicago to manage its vaccine distribution, and which the consultant is now looking to sell to other local governments.
  • Oracle donated a national electronic health record database and public health management applications to the federal government that can be used to detail who has been vaccinated and track any potential side effects. The data can also be used in aggregate so public officials can see at a glance where people have been vaccinated. Oracle is also working with the Tony Blair Institute to bring similar systems to Africa.
  • IBM is offering up a range of technologies to help governments and private companies, including supply chain management software as well as an open blockchain-based approach to record and authenticate the temperature and handling of each vaccine dose, including batch- and lot-level information.
  • Microsoft is working with a range of partners on vaccine management efforts, including consultancy Ernst and Young, which is tapping Microsoft's cloud and business services.
  • Google said its cloud unit has extended its pandemic response to help with vaccine intelligence and is working alongside partners to deploy vaccine management solutions with state and local governments.

The big picture: For tech, it's both a business opportunity and a chance for companies to tie themselves to a critical societal need.

Yes, but: Tech could also be positioning itself for blame if there are hiccups in these systems. Remember the rollout of Healthcare.gov?

Between the lines: What's tricky is there are so many players involved in getting the vaccine to the population, including the pharmaceutical companies, shippers like UPS and FedEx, state governments, local governments, hospitals, drugstore chains and individual providers.

  • There isn't going to be a single supply chain management system, meaning each of those players will need to build their own capability and share data with other parts of the system.
  • "This supply chain is enormously complex, probably more complex than any I’ve seen — and I worked with the defense industry," IBM VP Tim Paydos told Axios.

The vaccine is going to be in short supply for months, creating huge and competing demand and the need to make sure every available dose reaches someone in need.

  • Risks include everything from cyber and physical attacks to introduction of counterfeit vaccines, diversion of real vaccines to the black market, and mismanagement that leads to spoiled vaccines.
  • Plus, there isn't one vaccine, but rather a number of different ones, each with different requirements in terms of dosing, need for cold storage and other specifics unique to each vaccine.
  • "This is not something you want to be doing with pens and papers and sticky notes," Salesforce chief medical officer Ashwini Zenooz told Axios.

The big picture: Tech companies are doing more than just helping governments and health authorities distribute the vaccine.

  • Google, Facebook and Twitter are working to fight the information battle, posting authoritative information and aiming to clamp down on vaccine misinformation.
  • A number of companies, including IBM and Clear, aim to provide a "digital health pass" to institutions that want to require proof of vaccination, such as airlines, workplaces and schools.
  • Google and Apple still offer their exposure notification technology, which uses smartphone proximity to determine whether you have been in close contact with someone who later tests positive for COVID-19.

Go deeper

Jan 29, 2021 - World

EU grants conditional approval of AstraZeneca vaccine

Photo: Sunil Ghosh/Hindustan Times via Getty Images

The European Commission on Friday granted conditional approval of the Oxford-AstraZeneca coronavirus vaccine for people 18 years and older.

Why it matters: This is the third vaccine to receive approval from the commission, coming hours after the Emergency Medicines Agency recommended its authorization.

Jan 29, 2021 - Health

WHO says most pregnant women can now receive coronavirus vaccine

A doctor administering Moderna's coronavirus vaccine at a university hospital in Essen, Germany, on Jan. 18. Photo: Lukas Schulze/Getty Images

The World Health Organization has altered its guidance for pregnant women who wish to receive the coronavirus vaccine, saying now that those at high risk of exposure to the COVID-19 or who have comorbidities that increase their risk of severe disease, may be vaccinated.

Why it matters: The WHO drew backlash for its previous guidance that did not recommend pregnant women be inoculated with vaccines made by Pfizer-BioNTech or Moderna, even though data indicated that pregnancy increased the risk of developing severe illness from the virus.

You’ve caught up. Now what?

Sign up for Mike Allen’s daily Axios AM and PM newsletters to get smarter, faster on the news that matters.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!